Monitoring Fetal Somatic Cell Genome Editing In Vivo with Total-Body Positron Emission Tomography: Studies in Rhesus Macaques ( Macaca mulatta )
Human Gene Therapy · 01.07.2026 · 37 (13-14) · 579-587
DOI: 10.1177/10430342261438941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, online erschienen am 14.04.2026. Verfasst von Alice F Tarantal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gene Editing, Fetus. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCRR NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Translational development of somatic cell genome editing requires monitoring the extent of editing in the body at a given time, the specificity of editing, durability, and the potential for adverse events. A noninvasive approach that can identify edited cells in vivo is beneficial for addressing these and related questions. These studies used total-body positron emission tomography (PET) to identify somatic cell gene editing in vivo in fetal rhesus macaques. Rhesus dams were screened to confirm they were seronegative for AAV serotype 9 and Sa Cas9 antibodies, then selected for the study. Fetuses were administered a dual imaging vector (AAV9/ Sa Cas9 and AAV9/ PCSK9 gRNA/HSV-sr39TK) in utero using an ultrasound-guided fetal intrahepatic approach in the second trimester (10 12 vector genomes/fetus). After maternal intravenous administration of 9-(4-(18)F-Fluoro-3-[hydroxymethyl]butyl)guanine ((18)F-FHBG) (∼3 mCi/kg), PET imaging was performed in the second and third trimesters. PET imaging provided evidence of editing in the fetal liver, which was sustained. Appropriate insertion of the promoterless HSV-sr39TK reporter in frame with the PCSK9 gene was confirmed in the fetal liver near term using RNA sequencing, and correctly targeted insertions were observed. These studies have shown that total-body PET can provide insights into gene-edited somatic cells in utero and without evidence of adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Pediatrics, University of California, Davis, California, USA.
- Cell Biology and Human Anatomy, University of California, Davis, California, USA.
- California National Primate Research Center, University of California, Davis, California, USA.
- Biochemistry and Molecular Medicine, University of California, Davis, California, USA.
- Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California, USA.
ORCID-Profile: Alice F Tarantal, Henriette O'Geen
Förderung
- NIH HHS
- NCRR NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Tarantal, A. F., Martinez, M. L., Sanz, L., Lee, C. I., Yang, H., O'Geen, H., Hartigan-O'Connor, D. J., & Segal, D. J. (2026). Monitoring Fetal Somatic Cell Genome Editing In Vivo with Total-Body Positron Emission Tomography: Studies in Rhesus Macaques ( Macaca mulatta ). Human Gene Therapy, 37(13-14), 579-587. https://doi.org/10.1177/10430342261438941
Vancouver
Tarantal AF, Martinez ML, Sanz L, Lee CI, Yang H, O'Geen H, et al. Monitoring Fetal Somatic Cell Genome Editing In Vivo with Total-Body Positron Emission Tomography: Studies in Rhesus Macaques ( Macaca mulatta ). Human Gene Therapy. 2026;37(13-14):579-587. doi:10.1177/10430342261438941
BibTeX
@article{Tarantal2026,
author = {Tarantal, Alice F and Martinez, Michele L and Sanz, Lionel and Lee, Charles I and Yang, He and O'Geen, Henriette and Hartigan-O'Connor, Dennis J and Segal, David J},
title = {Monitoring Fetal Somatic Cell Genome Editing In Vivo with Total-Body Positron Emission Tomography: Studies in Rhesus Macaques ( Macaca mulatta )},
journal = {Human Gene Therapy},
year = {2026},
volume = {37},
number = {13-14},
pages = {579--587},
doi = {10.1177/10430342261438941}
}
EUVIMED